Effect of N-(3-hydroxy-1,3,5,(10)estratrien-17 beta-yl)-3-hydroxypropyl-amine (prolame) and estradiol-17 beta on platelet aggregation.
Baños
G
G
Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, México, D.F.
De la Peña
A
A
Izaguirre
R R
RR
Mandoki
J J
JJ
Mendoza-Patiño
N
N
Rubio-Póo
C
C
Fernández
J M
JM
D000244:Adenosine Diphosphate / Q000494:pharmacology; D000328:Adult; D000925:Anticoagulants / Q000494:pharmacology*; D004958:Estradiol / Q000494:pharmacology*; D004963:Estrenes / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*
D000925:Anticoagulants; D004963:Estrenes; D010975:Platelet Aggregation Inhibitors; D004958:Estradiol; D000244:Adenosine Diphosphate; C047867:prolame